Introduction/Background Pelvic exenteration is a treatment option for select patients with recurrent cervical cancer.

Methodology Total infralevator pelvic exenteration was performed in a 55-year old patient, who had undergone simple hysterectomy for cervical carcinoma and received adjuvant chemoradiotherapy 9 months ago. Even though the development of pelvic spaces was not succeeded as planned, total exenteration was performed by a gynecologic oncology team. Ileal conduit was preferred for urinary diversion. Surgical details (exenterative and reconstructive phases, in particular) were shown in this video.

Results Pathologically free margins were obtained. No adjuvant treatment was given. Follow-up at 11th month showed no evidence of recurrence.

Conclusion Pelvic exenteration should be considered in patients with central recurrence of cervical cancer.

Disclosure Nothing to disclose